Hspa9 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Heat Shock Protein Family A (Hsp70) Member 9 is encoded by the HSPA9 gene located on chromosome 5q31.2. This gene encodes mortalin, a mitochondrial Hsp70 family member essential for mitochondrial protein import, folding, and quality control. Mortalin is a multi-functional protein involved in mitochondrial biogenesis, cellular metabolism, stress response, and aging. HSPA9 is increasingly recognized as a Parkinson's disease susceptibility gene, with decreased expression observed in PD brains. [1]
| Gene Symbol | HSPA9 |
|---|---|
| Full Name | Heat Shock Protein Family A (Hsp70) Member 9 (Mortalin) |
| Chromosome | 5q31.2 |
| NCBI Gene ID | 3313 |
| OMIM | 604736 |
| Ensembl ID | ENSG00000113014 |
| UniProt ID | P38646 |
| Protein Length | 679 amino acids |
| Molecular Weight | 73.6 kDa |
HSPA9/Mortalin has a mitochondrial Hsp70 domain structure:
The N-terminal mitochondrial targeting sequence (residues 1-46) directs import to mitochondria. Mortalin lacks the C-terminal EEVD motif of cytosolic Hsp70s.
Mortalin performs essential mitochondrial functions:
HSPA9/Mortalin exhibits broad expression:
| Disease | Mechanism | Evidence |
|---|---|---|
| Parkinson's Disease | Reduced mortalin in SNpc; mitochondrial dysfunction | Human brain studies |
| Wolfram Syndrome | WFS1 interactor; diabetes mellitus | Genetic studies |
| Cancer | Elevated in many tumors; anti-apoptotic | Tumor expression |
| Aging | Declines with age; cellular senescence | Age-related studies |
| ALS | Mitochondrial dysfunction in motor neurons | Patient studies |
HSPA9/Mortalin in Parkinson's disease:
HSPA9/Mortalin as a therapeutic target:
HSPA9 knockout is embryonic lethal:
The study of Hspa9 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.